Cognitive heterogeneity in probable Alzheimer disease: Clinical and neuropathologic features.

We can reliably identify distinct cognitive profiles among patients with clinically diagnosed probable AD that are associated with tangle pathology and with different rates of decline. This may have implications for clinical trials in AD, especially therapies targeting tau.